N-Ethylnorketamine
This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:10, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H18ClNO |
Molar mass | 251.75 g·mol−1 |
3D model (JSmol) | |
| |
|
N-Ethylnorketamine (ethketamine, NENK, 2-Cl-2'-Oxo-PCE) is a designer drug which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. It has been sold over the internet since around September 2012, and identified in seized drug samples by analytical laboratories in the UK and other European countries.[1]
Legal Status
As of October 2015 NENK is a controlled substance in the United Kingdom,[2] China,[3] and the US state of Alabama.[4]
References
- ^ Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine Report (2012)
- ^ Explanatory Memorandum to the Misuse of Drugs (1971) Amendment Order 2013
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
- ^ "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd". March 2014. Retrieved 28 September 2015.
|
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |